Table E2.
Baseline characteristics of study participants
| Baseline characteristic | Patients with data in 2019 or 2020 (n = 1,178) |
|---|---|
| Age (y), mean (SD) | 47.7 (13.7) |
| Female | 987 (83.8%) |
| Race/ethnicity | |
| H/L | 588 (49.9%) |
| AA/B | 590 (50.1%) |
| Region of enrollment | |
| Southeast | 364 (30.9%) |
| Puerto Rico | 101 (8.6%) |
| Northeast | 473 (40.2%) |
| Southwest | 70 (5.9%) |
| Ohio Valley Central | 170 (14.4%) |
| BMI, mean (SD) | 35.1 (9.3) |
| ACT, mean (SD) | 14.7 (4.4) |
| ASUI, mean (SD) | 0.67 ± 0.21 |
| AEX within 12 months prior to randomization | 848 (72.0%) |
| Work outside home at baseline (n = 1,168) | |
| No | 639 (54.7%) |
| Yes | 529 (45.3%) |
| Medical history (n = 1,166) | |
| Heart disease | 104 (8.9%) |
| Diabetes | 293 (25.1%) |
| Hypertension | 481 (41.3%) |
| Depression | 423 (36.3%) |
| Sleep disorder | 407 (34.9%) |
| Allergies | 878 (75.3%) |
| COPD | 33 (2.8%) |
| Stroke | 43 (3.7%) |
| Chronic kidney disease | 26 (2.2%) |
ACT, Asthma Control Test; ASUI, Asthma Symptom Utility Index; BMI, body mass index; COPD, chronic obstructive pulmonary disease.